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ABSTRACT
Surgical correction of pelvic organ prolapse (POP) is a common procedure performed in the United States. The 2 most
widely used vaginal procedures for correction of POP in women with stress urinary incontinence (SUI) are sacrospinous
ligament fixation (SSLF) and uterosacral ligament suspension (ULS). No comparative studies have examined the effi-
cacy and safety of these 2 procedures. Behavioral therapy with pelvic floor muscle training (BPMT) is an effective
stand-alone therapy for pelvic floor symptoms in women with SUI and may be a logical adjunct to surgery. However,
it is unknown whether preoperative BPMT improves prolapse outcomes after surgery.
The OPTIMAL study was a multicenter, 2  2 factorial, randomized trial designed to compare surgical outcomes of
SSLF and ULS after vaginal surgery in women with prolapse and SUI. The trial also compared the effect of perioper-
ative BPMT and usual care on surgical outcomes in this patient population. Women were treated at 9 US medical centers
between 2008 and 2013. The 2-year follow-up rate was 84.5%. Women undergoing surgery for POP and SUI underwent
2 randomizations, the first to perioperative BPMT (n = 186) or usual care (n = 188), and the second to SSLF (n = 186) or
ULS (n = 188). Participants were masked to their surgical group assignment, and study surgeons were masked to the
physical therapy group assignment. The primary surgical outcome was success at 2 years defined as the following:
(1) no apical descent more than one-third into vaginal canal or anterior or posterior vaginal wall decent beyond the hy-
men (anatomic success), (2) no bothersome vaginal bulge symptoms, and (3) no retreatment for prolapse. Primary out-
comes for BPMT were evaluated at 6 and 24 months. The primary behavioral outcome at 6 months, urinary symptom
scores, was assessed using Urinary Distress Inventory (range, 0–300, higher scores indicate worse condition). The
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primary 24-month outcome, prolapse symptom scores, was assessed using the Pelvic Organ Prolapse Distress Inventory
(range, 0–300) and anatomic success.
At 2 years, there was no significant difference between the 2 groups in surgical success rates (ULS, 59.2% [93/157] vs
SSLF, 60.5% [92/152]); the unadjusted difference was 1.3%, with a 95% confidence interval (CI) of 12.2% to 9.6%, and
an adjusted odds ratio of 0.9, with a 95% Cl of 0.6 to 1.5. There was also no difference between groups in serious adverse
event rates (ULS, 16.5% [31/188] vs SSLF, 16.7% [31/186]; unadjusted difference 0.2% [95%CI, 7.7% to 7.4%] and
adjusted odds ratio 0.9 [95% CI, 0.5–1.6]). With respect to behavioral intervention, perioperative BPMT did not produce
greater improvements either in urinary scores at 6 months (adjusted treatment difference, 6.7; 95%CI, 19.7 to 6.2), or
prolapse scores at 24 months (adjusted treatment difference, 8.0; 95%CI, 22.1 to 6.1), or anatomic success at 24 months.
These data show that there was no significant difference between ULS and SSLF for anatomic, functional, or adverse
event outcomes 2 years after vaginal surgery in women with prolapse and SUI. Moreover, the finding that perioperative
BPMT did not improve urinary symptoms or prolapse outcomes suggests that this behavioral intervention is unnecessary
for routine care in most women undergoing such surgery.
EDITORIAL COMMENT
(Clinical practices for vault suspension in pa-
tients with apical prolapse have traditionally been
informed by surgeon comfort with the chosen
technique or a perception of improved efficacy in
certain scenarios. For instance, a surgeon treating
a patient with severe or recurrent prolapse or a
young patient might choose an abdominal sacral
colpopexy with mesh over a vaginal approach
because of evidence that it offers a lower risk of
apical recurrence. Nonetheless, the vast majority
(80%–90%) of apical suspension procedures done
in the United States are done by a transvag-
inal route (Boyles SH, Am J Obstet Gynecol
2003;188(1):108–115). This means either clini-
cians treating prolapse are not comfortable offer-
ing sacral colpopexy, or they or their patients
prefer it, for any of a variety of reasons including
but not limited to patient comorbidities, perceived
easier recovery of vaginal surgery, or avoidance of
permanent mesh graft. (Certainly some of these
vaginal procedures incorporate a permanent mesh
graft anyway.) However, it is important to recognize
that vaginal surgery is being done for apical pro-
lapse despite evidence of less favorable apical du-
rability when compared with sacral colpopexy.
There are a few significant randomized trials of api-
cal repairs, but each compared a vaginal to an ab-
dominal (open or laparoscopic) technique.
Until the OPTIMAL trial described here, there
has been no randomized trial comparing 2 vagi-
nal techniques. Published studies and trials
describing outcomes after transvaginal surgical
treatment of vaginal or uterovaginal prolapse are
widely available but consist primarily of case se-
ries or cohorts for either SSLF or, more recently,
ULS. Some 22 published studies with sample
size of 50 or more subjects undergoing SSLF are
available. These studies describe success rates
that vary greatly according to the definition of suc-
cess used, but generally describe a 70% to 90%
2- to 3-year success rate with rates of reoperation
of less than 10%. Perhaps because of the rela-
tively dorsal and often right-sided retroflexion of
the vaginal apex with SSLF, anterior compartment
recurrences are most common. Concern about
these features led many surgeons in the United
States to adopt the ULS as a go-to transvaginal
apical repair, despite the fact that only about 7
poorly controlled retrospective studies described
its use. These studies describe an 82% to 96%an-
atomic success rate but also a 1% to 11% risk of
ureteral injury. (For details of the literature existing
regarding these 2 procedures, an excellent sum-
mary is Maher C, Cochrane Database Syst Rev
2013;4:CD004014.)
A randomized trial of surgery for prolapse pro-
vided a good opportunity to also test the efficacy
of perioperative pelvic floor physical therapy as
well. There is good evidence that BPMT improves
symptoms of a variety of pelvic floor disorders,
with little or no risk. Evidence of its efficacy in the
perioperative period is very limited, however, with
poorly described interventions or limited postop-
erative follow-up. This makes studying BPMT in
this setting very attractive, but testing both these
interventions in 1 study is legitimate only if any
effect of the surgical vault suspension technique
were to be independent of any effect fromwhether
a subject performed BPMT per protocol or was
assigned to usual perioperative care.
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The investigators designing the OPTIMAL trial
assumed this would be the case and used a fac-
torial design with 2 independent randomizations,
allowing them to obtain level I data for both the
surgical (SSF vsULS) and physical therapy (BPMT
vs usual care) interventions. Women entering into
the study had to have stage 2 to 4 POP by the
POPquantification systemmeasures, with descent
of the cervix or apex at least one-half way into the
vagina, and symptoms of bulge. All women had
to demonstrate SUI and have plans to undergo a
midurethral sling procedure to treat the inconti-
nence. This criterion helped to standardize the
postoperative support of the distal anterior vagi-
nal wall and isolated the surgical effect on the
patient’s prolapse to the apex support from
the SSF or ULS, and any anterior colporrhaphy.
The studywas powered to detect a 15%difference
between surgical success rates, defined using a
composite outcome as described above. Two-year
follow-upwas high at 84.2%, and CONSORT data
of subject progression through the study period
are clearly described in the full manuscript.
Study findings are remarkably consistent, with
no significant differences found between SSLF
versus ULS for the primary composite outcome
at 24 months, nor were there any differences be-
tween postoperative symptom scores or prolapse
at 24 months between BPMT and usual care
groups. Surgical success rates at 24 months
were about 60% in both groups, relatively lower
than previously reported studies of SSLF or ULS,
but this is likely because of the rigorously defined
composite outcome that was used to define sur-
gical success. Symptoms of vaginal bulge post-
operatively (one of the elements of the primary
composite outcome) were present in only about
20% of subjects in both groups, and this is nota-
ble because absence of bulge has been cited in
multiple studies as the outcome most consis-
tently associated with patient satisfaction.
The authors did report detecting some unex-
pected interactions between the 2 interventions;
for instance, women who received ULS and also
BPMT had more apical vaginal descent post-
operatively than did women receiving SSLF and
BPMT. The reasons for this finding are unclear,
but they emphasize the potential risks of a facto-
rial design.
The clinical implications of this study are not
necessarily generalizable to all women having
prolapse and incontinence surgery. For instance,
while the study does not support additional ben-
efits for women with prolapse and SUI embark-
ing on a program of BPMT in the perioperative
period, it does not mean that a woman who does
not plan surgery or who develops new symp-
toms postoperatively would not benefit from
pelvic floor therapy. Similarly, it does not mean
SSLF and ULS procedures are equivalent in all
clinical settings. Nonetheless, it is reasonable
to use SSLF or ULS in specific circumstances
and anticipate similar outcomes with regard to
prolapse. For instance, for a patient with post-
hysterectomy vaginal vault prolapse, in whom in-
traperitoneal entry may be difficult, it would be
reasonable to routinely perform SSLF. It may be
reasonable to routinely perform ULS in the con-
text of hysterectomy for uterovaginal prolapse
where the peritoneum is already open. The OPTI-
MAL study also provides rigorous documenta-
tion of outcomes for these 2 commonly performed
procedures, facilitating comparisons to other
methods of vault suspension such as current
transvaginal mesh procedures and sacral colpo-
pexy. Hopefully, more such studies will be soon
in progress to inform clinicians counseling pa-
tients with prolapse.—ACW)
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